Skip to content

Vivani Medical VANI Shares (Diluted)

Shares (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
895.9M-0.5%
Amgen logo
AmgenAMGN
544M+0.6%
Altimmune logo
AltimmuneALT
124.5M+64.7%
Viking Therapeutics logo
Viking TherapeuticsVKTX
115.6M+3.1%
Wave Life Sciences logo
Wave Life SciencesWVE
200.2M+23.1%
Prime Medicine logo
Prime MedicinePRME
177.1M+35.3%

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's shares (diluted)?
Vivani Medical (VANI) reported shares (diluted) of 81.3M in Q1 2026.
How has Vivani Medical's shares (diluted) changed year-over-year?
Vivani Medical's shares (diluted) increased by 37.2% year-over-year, from 59.2M to 81.3M.
What is the long-term trend for Vivani Medical's shares (diluted)?
Over 3 years (2021 to 2025), Vivani Medical's shares (diluted) has grown at a 26.5% compound annual growth rate (CAGR), from 118.8M to 240.6M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.